Streamlining and Improving Hemophilia Treatment and Care
Adjustments can be made that would improve and streamline hemophilia care, according to a panel of experts whose discussion was published in Blood Transfusion.
Recombinant Treatment Drug Approval Sought for von Willebrand Disease
Producers of a von Willebrand factor recombinant treatment are seeking a biologics license after already being granted orphan drug status by the FDA.
Quality of Life and Age Related for Hemophilia Patients
Age and quality of life in hemophilia patients is linked, according to research published in Blood Transfusion.
Hemophilia B Gene Therapy Trial Effective and Saves Money
A gene therapy treatment for men with hemophilia B proved effective, and the researchers involved in the study estimate it saved $2.5 million for the trial's patients.
Annualized Bleeding Rates Reduced Using Treatment with Turoctocog Alfa
Turoctocog alfa reduced annualized bleeding rates in hemophilia A patients in a phase 3 clinical trial from Novo Nordisk.
Analysis of Current Challenges Facing Hemophilia Patients and Physicians
Researchers examine the current issues facing hemophilia patients and physicians and potential solutions to the issues in the quarterly journal Blood Transfusion.
2 Commerce Drive Cranbury, NJ 08512